U.S. Biomaterials Market Is Set For Lucrative Growth To 2030

U.S. Biomaterials Market Summary

The U.S. biomaterials market size was estimated at USD 59.3 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 14.8% from 2024 to 2030. The increasing demand for biomaterials is strongly linked to the rise in accidental injuries and the growing prevalence of chronic diseases across the country. Additionally, the expanding application of advanced biomaterials in the repair and replacement of tissues—such as bones, teeth, and other vital organs—is a key factor contributing to this growth. Technological developments, especially those involving nanotechnology for molecular-level treatments, have further fueled innovation in this field.

Moreover, the scope of biomaterial usage is broadening across several healthcare domains. Applications include tissue engineering, medical 3D printing, implant development, nanomaterials, diagnostic systems, biotechnology, bioimaging, and regenerative medicine, among others. These advancements are making biomaterials indispensable to modern healthcare systems, improving patient outcomes while enabling more precise, personalized treatments. The rising focus on biocompatibility and functionality is also pushing researchers and manufacturers to develop next-generation biomaterials that address both clinical and patient-specific needs.

In 2023, the U.S. accounted for more than 33.3% of the global biomaterials market, highlighting its leadership position in this sector. One of the major drivers is the increasing need for orthopedic implants, particularly due to the aging population, which is more prone to conditions like osteoarthritis, osteoporosis, and other musculoskeletal disorders (MSDs). The growing prevalence of skeletal and joint-related ailments has led to higher demand for implants composed of biomaterials, directly supporting market expansion. Additionally, the COVID-19 pandemic has driven innovation in biomedical devices for virus detection, increasing the application of biomaterials in diagnostic and therapeutic areas.

Key Market Trends & Insights

• Metallic biomaterials dominated the market in 2023, accounting for the largest revenue share of 40.2%. Metals are commonly used in dental and orthopedic applications due to their strength, durability, and load-bearing capacity. As a result, they remain the most widely adopted type of biomaterials, especially in manufacturing implants that require mechanical stability. The high usage rate of metallics can also be attributed to their proven track record in clinical performance, particularly in long-term implantable devices.
• In terms of application, the orthopedic segment held the largest market share at 25.2% in 2023. A significant number of patients undergo treatments involving biomaterials to manage and treat various bone and joint-related degenerative conditions. These applications include joint replacements, bone grafts, and prosthetics, all of which depend heavily on advanced biomaterials for improved integration and recovery outcomes. The continuous rise in orthopedic procedures further contributes to the overall market expansion.
• Plastic surgery is projected to register the fastest CAGR of 18.0% during the forecast period. The increased availability and diversity of commercial biomaterial products have significantly contributed to this growth. In recent years, the use of biomaterials in plastic and reconstructive surgeries has surged due to their adaptability, improved safety profiles, and enhanced aesthetic results. These materials are now used in procedures ranging from skin grafts and facial reconstruction to breast implants and cosmetic enhancements.

Order a free sample PDF of the U.S. Biomaterials Market Intelligence Study, published by Grand View Research.

Market Size & Forecast

• 2023 Market Size: USD 59.3 billion
• 2030 Projected Market Size: USD 155.2 billion
• CAGR (2024 - 2030): 14.8%

Key Companies & Market Share Insights

Leading companies invest heavily to broaden their reach and retain a competitive advantage. They employ agreements, partnerships, and collaborative models to enhance their product range. Furthermore, primary suppliers are leaning towards creating more innovative products to broaden their selection of biomaterials. For example, in April 2023, Novo Nordisk partnered with Aspect Biosystems, specializing in bioprinting biomaterials, to develop bioprinted tissue treatments for obesity and diabetes.

Key Players

• Medtronic plc
• Evonik Industries AG
• Carpenter Technology Corporation
• Berkeley Advanced Biomaterials
• Invibio Ltd.
• Zimmer Biomet Holdings, Inc.
• BASF SE
• Covalon Technologies Ltd.
• Stryker
• Johnson & Johnson
• Corbion
• Collagen Matrix, Inc.

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion

In conclusion, the U.S. biomaterials market is on a strong growth trajectory driven by rising healthcare needs, increasing chronic conditions, and continuous advancements in biomedical technologies. The country’s significant contribution to the global market underscores its role in research and innovation. Applications in orthopedics, dental care, plastic surgery, and diagnostic tools are rapidly expanding, supported by technological integration and evolving medical requirements. The dominance of metallic biomaterials and the accelerating adoption in plastic surgery reflect shifting industry trends. As the healthcare sector continues to demand more efficient, biocompatible solutions, biomaterials are set to play a critical role in shaping future treatment landscapes.